
The Clorox Company (NYSE:CLX – Free Report) – Research analysts at Zacks Research lowered their Q3 2027 earnings estimates for shares of Clorox in a report released on Monday, November 16th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $1.53 for the quarter, down from their previous forecast of $1.56. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for Clorox’s current full-year earnings is $5.74 per share. Zacks Research also issued estimates for Clorox’s Q4 2027 earnings at $1.60 EPS, Q1 2028 earnings at $1.29 EPS, Q2 2028 earnings at $1.34 EPS, Q3 2028 earnings at $1.74 EPS, Q4 2028 earnings at $1.65 EPS, FY2028 earnings at $6.01 EPS and Q1 2029 earnings at $1.36 EPS.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.48. The company had revenue of $1.91 billion during the quarter, compared to the consensus estimate of $1.88 billion. Clorox had a net margin of 9.41% and a return on equity of 608.30%. The firm’s quarterly revenue was up 33.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.85 EPS.
View Our Latest Research Report on CLX
Clorox Stock Up 1.6%
Shares of CLX opened at $108.40 on Tuesday. The firm has a 50 day simple moving average of $89.77 and a two-hundred day simple moving average of $99.51. The company has a debt-to-equity ratio of 32.91, a current ratio of 0.65 and a quick ratio of 0.39. Clorox has a one year low of $79.12 and a one year high of $128.90. The company has a market cap of $13.13 billion, a P/E ratio of 17.10, a P/E/G ratio of 3.38 and a beta of 0.59.
Institutional Trading of Clorox
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. bought a new position in shares of Clorox in the 2nd quarter valued at $958,640,000. Beutel Goodman & Co Ltd. bought a new stake in Clorox during the 3rd quarter worth $163,038,000. Bank of America Corp DE bought a new stake in Clorox during the 2nd quarter worth $179,780,000. ProShare Advisors LLC grew its position in Clorox by 6.3% during the 3rd quarter. ProShare Advisors LLC now owns 1,737,891 shares of the company’s stock worth $140,787,000 after acquiring an additional 102,732 shares during the last quarter. Finally, Equity Investment Corp increased its holdings in Clorox by 34.8% in the 3rd quarter. Equity Investment Corp now owns 1,578,983 shares of the company’s stock worth $127,913,000 after purchasing an additional 407,569 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.
Insider Transactions at Clorox
In related news, Director Pierre Breber acquired 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 4th. The stock was acquired at an average price of $100.06 per share, with a total value of $400,240.00. Following the purchase, the director directly owned 22,000 shares in the company, valued at approximately $2,201,320. This trade represents a 22.22% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.51% of the stock is currently owned by corporate insiders.
Clorox Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 12th. Investors of record on Wednesday, January 27th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date is Wednesday, January 27th. Clorox’s dividend payout ratio is currently 89.93%.
Recent Clorox Headlines
Investors following CLX have been watching these headlines:
- Positive Sentiment: Clorox declared a regular quarterly dividend of $1.25 per share, or $5.00 annualized. The dividend supports shareholder returns; the stated yield is 4.7%. Dividend announcement
- Neutral Sentiment: Clorox Purell ProCare introduced new healthcare disinfecting wipes and a touch-free dispensing system at an industry trade show. The launches could support its healthcare business, though no sales or earnings impact was disclosed. Product announcement
- Negative Sentiment: Zacks Research cut estimates across several upcoming quarters and fiscal years, including FY2028 EPS to $6.01 from $6.23 and FY2029 EPS to $6.20 from $6.89; it also lowered its Q2 2027 forecast to $1.02 from $1.30. The firm maintains a “Strong Sell” rating. These revisions suggest weaker expected earnings, although Zacks raised its FY2027 estimate to $5.71 from $5.53. Clorox analyst coverage
About Clorox
The Clorox Company is a consumer products company founded in 1913 and headquartered in Oakland, California. It makes and markets products for household cleaning, food, water filtration, personal care and pet care. Its portfolio includes Clorox disinfecting and cleaning products, Glad trash bags and food-storage products, Kingsford charcoal, Brita water filters, Hidden Valley dressings and sauces, Burt’s Bees personal-care products, and Fresh Step cat litter. The company also sells products under brands such as Pine-Sol and Liquid-Plumr.
Read More
- Five stocks we like better than Clorox
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
